Patent · US Active

Variants of CRISPR from Prevotella and Francisella 1 (Cpf1)

US11168313B2 · kind B2 · utility

2Cited by
0References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 25, 2017
Grant dateNov 9, 2021
Priority date—
Expiry dateJul 25, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Engineered CRISPR from Prevotella and Francisella 1 (Cpf1) nucleases with altered and improved target specificity and their use in genomic engineering, epigenomic engineering, genome targeting, genome editing, and in vitro diagnostics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.